25th year logo

Premier Investor Relations Services for Healthcare and Biotechnology Companies Worldwide

We believe that a successful investor relations program depends on a multifaceted approach, including thoughtful strategy and seamlessly executed tactics.

Our goal is to help every company we work with achieve a valuation that reflects its accomplishments, technology and assets through enhanced visibility and communications and through favorable and credible interactions within the investment community and other key audiences.

From private to public, preclinical to commercial, we help companies at all stages map out a strategic plan to thoughtfully engage with the financial community, position themselves as leaders in their space, and reach their financing goals. Stern IR is proud to contribute to these efforts to provide novel approaches to people in need.

Our Services


Investor & Industry Events

We help plan and run virtual and live events for our clients that attract key investors, analysts and other stakeholders, including:

  • Traditional analyst and investor R&D days
  • KOL roundtables
  • Events at medical meetings.
  • Premier corporate access event around the JP Morgan Healthcare Conference in January in San Francisco

Sell-Side Engagement

Stern IR also facilitates relationships with the sell-side (equity research and investment banking) and can serve as a liaison.


Messaging and Positioning

Our deep industry knowledge and research on best practices assist each client in crafting key messages. Integrating vision, the value and impact of scientific innovation, differentiation from peers, and specific expertise into a thoughtful story that resonates with investors is key to building credibility and value.


Preparing for Life as a Public Company

We work with companies from the very early stages –supporting the company branding and website development and the Series A financing and public launch, all the way through an IPO, SPAC, reverse merger, or new exchange listing. We assist with everything along the way and beyond:

  • Crossover rounds
  • Banking introductions
  • Syndicate selection and bake-off
  • S-1 / F-1 drafting
  • Testing-the-waters and roadshow meetings support
  • Development and integration of IR website

Newsflow Planning

Planning how, when, and where to strategically disclose clinical, corporate, and financial news to generate the most value possible is a key element to our approach. We will draft your announcements with a focus on your strategic positioning.


Investor Targeting & Outreach

Stern IR has extensive knowledge and resources to help clients identify the right healthcare and biotechnology investors. We help manage these relationships and also handle outreach and scheduling.